IJCRR - Vol 07 Issue 08, April, 2015
THE STUDY OF PERIPHERAL NEUROPATHY AND AUTONOMIC NEUROPATHY PREVALENCE IN TYPE 2 DIABETES MELLITUS
Author: Bezwada Srinivasa Rao, Madu Anu Radha M. D., Matta Sree Vani M. D.
Background: Type 2 diabetes and its complications are major causes of morbidity and mortality with decreased quality of life. Distal symmetrical poly neuropathies affecting sensory more than motor nerves are common long term micro vascular complications. Prevalence of both peripheral and autonomic neuropathy increases with increased duration of type 2 diabetes. Tight glycemic control and lowering of glycosylated hemoglobin levels are associated with improvement of symptoms and slowing the progression of diabetic neuropathy.
Aim: The aim is to study the prevalence of peripheral neuropathy and autonomic neuropathy and their relation with duration of type 2 diabetes.
Materials and Methods: The present study enrolled 100 patients of type 2 diabetes with age > 30 yrs. Gestational and type1 diabetes patients were excluded from the study. Screening of neuropathy was done by monofilament and vibration tests. Nerve conduction studies were done to confirm neuropathy. Standard tests for autonomic dysfunction like orthostatic hypotension, pulse rate response to deep breaths test, hand grip and valsalva manoeuvre were performed.
Results: In this study, the prevalence of neuropathy was 57% in diabetic patients. Out of 57 patients with neuropathy, 25 patients (43.85%) had only peripheral neuropathy, 6 patients (10.53%) had only autonomic neuropathy and 26 patients (45.62%) had both peripheral and autonomic neuropathy. Prevalence of both peripheral and autonomic neuropathy increased with increased duration of type 2 diabetes.
Conclusions: The most common form is the distal symmetrical poly neuropathy than autonomic neuropathy. Both peripheral and autonomic neuropathies do not invariably coexist in diabetes. Peripheral and autonomic neuropathy increased with increased duration of type 2 diabetes.
Keywords: Autonomic neuropathy, Glycosylated hemoglobin, Micro vascular complications, Nerve conduction studies, Symmetrical poly neuropathy, Type 2 diabetes mellitus
Bezwada Srinivasa Rao, Madu Anu Radha M. D., Matta Sree Vani M. D.. THE STUDY OF PERIPHERAL NEUROPATHY AND AUTONOMIC NEUROPATHY PREVALENCE IN TYPE 2 DIABETES MELLITUS International Journal of Current Research and Review. Vol 07 Issue 08, April, 28-33
1. Marchal de Calvi CJ. Recherchessur les accidents diabetiques P Asselin, 1894\
2. Ellenberg M. Diabetic neuropathic cachexia. Diabetes 1974;23:418-423.
3. Tesfaye S, Malik R, Harris N, et al. Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia 1996; 329-335.
4. Korczyn AD. Bell’S palsy and diabetes mellitus. Lancet 1971;1:108-109.
5. Malik RA, Newrick PG, Sharma AK, et al. Microangiopathy in human diabetic neuropathy : relationship between capillary abnormalities and the severity of neuropathy Diabetologia 1989; 32 : 92-102
6. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications : a new perspective on an old paradigm. Diabetes 1999; 48:1-9.
7. Jennings PE, Chirico S, Lunec J, et al, Vitamin C metabolites and microangiopathy in diabetes mellitus. Diabetes Res 1987; 6: 151-154.
8. Matinez – Blasco A, Bosch – Morell F, Trenor C, et al. Experimental Diabetic neuropathy: role of oxidative stress and mechanisms involved. Biofactors 1998; 8: 41-43.
9. SampathD, Jackson GR, Werbach – Perez K, et al., Effects of nerve growth factor on glutathione peroxidase and catalase on PC 12 cells J N eurochem 1994; 62: 2476-2479.
10. Kassander P. Asymptomatic gastric retention in diabetics (gastroparesis deabeticorum). Ann Intern Med 1958; 48 : 797-812.
11. Ewing DJ, Campbell IW, Clarke BF, Heart rate changes in diabetes mellitus. Lancet 1981; 1: 183-186.
12. Lloyd-Mostyn RH, Watkins PJ. Defective innervations of heart in diabetic autonomic neuropathy. BMJ. 1975; 3 : 15- 17.
13. Mc Culloch Dk, Campbell IW, Wu FC, et al. The prevalence of diabetic impotence. Diabetologia 1980; 18 : 279-283.
14. Stuart DD. Diabetic gustatory sweating. Ann Intern Med 1978; 89 : 223-224.
15. The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country, Diabetology and Metabolic Syndrome 2012, 4:21, Prasad Katulanda, Priyanga Ranasinghe, RanilJayawardena, Godwin R Constatine, M H R Sheriff and David R Matthews.
16. Explorative study on diabetes neuropathy among type II diabetic patients in UniversitiSains Malaysia Hospital, SalwaSelim Ibrahim Abougalambou, Ayman SelimAbougalambou, Discipline of Clinical Pharmacy, School of Phar-maceutical Sciences, UniversitiSains Malaysia (USM), Malaysia, King Abdhullah Medical City, Saudi Arabia.
17. Peripheral neuropathy does not invariable coexist with autonomic neuropathy in diabetes mellitus by N. Tentolouris, S. Pagoni, A. Tzonou, N. Katsilambros, First Department of Propaedeutic Medicine, Athens University Medical School, ‘Laiko’ Epidemiology, Athens University Medical School, Athens, Greece.
18. A population-based study by Philip A. Low, MD, Lisa M. Benrud-Larson, PHD, David M. Sletten, Tonette L. OpferGehrking, Stephen D. Weigand, MS, Peter C. O’Brien, PHD, Guillermo A. Suarez, MD and Peter J. Dyck, MD.
19. R Schandry, M Lobisch, Importance of sensory symbptoms in identifying patients with diabetic peripheral neuropathy, published in Practical Diabetes International, January/February 2007.